NYSE:DHRLife Sciences
Danaher’s €3b Euro Debt Issue And What It Means For Valuation
Danaher (NYSE:DHR) has launched a major euro-denominated debt offering of nearly €3b in senior notes.
The financing is intended to help fund Danaher’s pending acquisition of Masimo Corporation.
The senior notes have been priced and are expected to close in the near term.
Danaher operates across life sciences, diagnostics and related technologies, and the planned acquisition of Masimo would expand its presence in patient monitoring and medical devices. By turning to euro-denominated senior...